# Biocare Medical acquires Empire Genomics

Biocare Medical, a provider of IHC and FISH instrumentation and reagents, announced the acquisition of Empire Genomics, a market leader in molecular biomarkers for cancer research and diagnostics. The acquisition expands Biocare Medical's molecular portfolio to over 1 million biomarkers.

- Type: Acquisition
- Announced: 2022-11-22
- Where: United States
- Status: announced
- Products: molecular biomarkers, FISH probes, IHC reagents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Biocare Medical](https://endata.com/companies/39171.md) (acquirer)
- [Empire Genomics](https://endata.com/companies/66804.md) (target)

## Sources

- [empiregenomics.com](https://empiregenomics.com/biocare-medical-acquires-empire-genomics/), 2022-11-22: "We are incredibly excited to welcome Empire Genomics to the Biocare Medical team."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.